| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.12B | -3.0% |
| Cost of Revenue | $3.35B | -3.5% |
| R&D Expense | $71.0M | -4.1% |
| SG&A Expense | $805.0M | -5.0% |
| Operating Income | $735.0M | +4.1% |
| Interest Expense | $176.0M | -14.1% |
| Pre-tax Income | $546.0M | +10.1% |
| Income Tax | $167.0M | +59.0% |
| Net Income | $378.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $657.0M | +10.8% |
| Accounts Receivable | $1.01B | -0.1% |
| Inventory | $756.0M | +3.0% |
| Current Assets | $2.81B | +3.4% |
| Total Assets | $7.60B | +4.8% |
| Current Liabilities | $1.37B | +1.1% |
| Long-term Debt | $3.18B | -6.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $649.0M | +12.7% |
| Capital Expenditures | $196.0M | +40.0% |
| Investing Cash Flow | -$212.0M | +51.8% |
| Financing Cash Flow | -$401.0M | -99.5% |
| Free Cash Flow | $453.0M | +3.9% |
| -3.3% |
| EPS (Basic) | $1.75 | -1.7% |
| EPS (Diluted) | $1.74 | -2.2% |
| Total Liabilities |
| $5.21B |
| -1.6% |
| Stockholders' Equity | $2.35B | +22.7% |